Wednesday 3 June 2009

What the Drug Companies Won't Tell You

Dr. Murray, widely regarded as one of the world's leading authorities on natural
medicine, has a new book out June 30th - "What the Drug Companies Won't Tell You And
Your Doctor Doesn't Know." The book argues that our reliance on medications to cure
us is at the core of America's health crisis, and shows stunning evidence that
pharmaceutical treatments for common diseases are often ineffective and result in
serious, widespread side effects - the existence of which is frequently hidden from
the public.

Here are just some of the shocking facts about drug companies that he chronicles -
with proof - in his book:

v According to a noted Harvard cardiologist and published studies in the Journal of
the American Medical Association, more than 80 percent of coronary angioplasty and
bypass operations are not necessary.

v Since statins were introduced in 1987, the number of people in the United States
with high cholesterol has increased from 13 million to nearly 100 million.

v It is estimated that 70 percent of patients with chronic daily headaches suffer
from drug-induced headaches.

v Aspirin, ibuprofen, and other nonsteroidal drugs (NSAIDs) used for arthritis lead
to joint destruction by inhibiting the formation of cartilage.

v Acetaminophen overdose is the leading cause of acute liver failure and causes 10
percent of all cases of kidney failure.

v Drugs like Paxil, Zoloft, and Prozac contribute to obesity, but weight gain is
not listed as a common side effect of these drugs.

v It is estimated that drug companies spend more than $57.5 billion a year
marketing to physicians--With about 700,000 practicing physicians in the United
States, it is estimated that the drug industry spends about $60,000 in marketing per
physician annually.

v According to a very detailed analysis by two Canadian researchers, Marc-André
Gagnon and Joel Lexchin, drug companies spend twice as much money on marketing as on
research and development.

v There is now considerable evidence that the drug companies exert significant
control over the FDA and the drug approval process.

No comments: